AstraZeneca suffers diabetes drug setback for COVID

British pharmaceutical giant AstraZeneca on Monday said that following a trial, its diabetes drug Farxiga was not successful in treating COVID patients at risk of severe complications.

Psychology & Psychiatry

Age-adjusted suicide rates decreased from 2018 to 2019 in US

(HealthDay)—From 1999 through 2018, there was an increase in age-adjusted suicide rates, followed by a significant decrease from 2018 to 2019, according to a February data brief published by the U.S. Centers for Disease ...


Remdesivir for COVID-19: FDA approved but still unproven

The United States has become the epicenter of the world in the ever increasing pandemic of COVID-19. While public health prevention strategies of social distancing, crowd avoidance, masking and frequent hand washing are of ...


COVID-19 mitigation measures tied to fewer preterm births

(HealthDay)—Initial implementation of national COVID-19 mitigation measures in the Netherlands was associated with a substantial reduction in the incidence of preterm births in the following months, according to a study ...


Why we should trust registered clinical trials

In a time when we have to rely on clinical trials for COVID-19 drugs and vaccines, a new study in the Proceedings of the National Academy of Sciences (PNAS) brings good news about the credibility of registered clinical trials.

page 1 from 4